XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
COMMON STOCK
CAPITAL IN EXCESS OF PAR VALUE
RETAINED EARNINGS
TREASURY SHARES
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
DEFERRED COMPENSATION
Beginning balance (in shares) at Sep. 30, 2021   84,375          
Beginning balance (in shares) at Sep. 30, 2021         27,762    
Balance at Sep. 30, 2021 $ 807,158 $ 21,094 $ 602,181 $ 669,998 $ (416,850) $ (45,977) $ (23,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 19,298     19,298      
Dividend (4,739)     (4,739)      
Shares withheld on employee taxes on vested equity awards (in shares)         422    
Shares withheld on employee taxes on vested equity awards (10,886)       $ (10,886)    
Amortization of deferred compensation 591           591
Equity awards granted, net (in shares)   113     0    
Equity awards granted, net 0 $ 28 (28)        
ESOP allocation of common stock 848   848        
Stock-based compensation 2,866   2,866        
Other comprehensive income, net of tax (2,751)         (2,751)  
Ending balance (in shares) at Dec. 31, 2021   84,488          
Ending balance (in shares) at Dec. 31, 2021         28,184    
Balance at Dec. 31, 2021 812,385 $ 21,122 605,867 684,557 $ (427,736) (48,728) (22,697)
Beginning balance (in shares) at Sep. 30, 2021   84,375          
Beginning balance (in shares) at Sep. 30, 2021         27,762    
Balance at Sep. 30, 2021 807,158 $ 21,094 602,181 669,998 $ (416,850) (45,977) (23,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 84,987            
Other comprehensive income, net of tax 2,198            
Ending balance (in shares) at Mar. 31, 2022   84,746          
Ending balance (in shares) at Mar. 31, 2022         27,714    
Balance at Mar. 31, 2022 883,214 $ 21,187 603,624 744,894 $ (420,606) (43,779) (22,106)
Beginning balance (in shares) at Dec. 31, 2021   84,488          
Beginning balance (in shares) at Dec. 31, 2021         28,184    
Balance at Dec. 31, 2021 812,385 $ 21,122 605,867 684,557 $ (427,736) (48,728) (22,697)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 65,689     65,689      
Dividend (5,352)     (5,352)      
Amortization of deferred compensation 591           591
Equity awards granted, net (in shares)   258     (470)    
Equity awards granted, net 0 $ 65 (7,195)   $ 7,130    
ESOP allocation of common stock 638   638        
Stock-based compensation 4,314   4,314        
Other comprehensive income, net of tax 4,949         4,949  
Ending balance (in shares) at Mar. 31, 2022   84,746          
Ending balance (in shares) at Mar. 31, 2022         27,714    
Balance at Mar. 31, 2022 883,214 $ 21,187 603,624 744,894 $ (420,606) (43,779) (22,106)
Beginning balance (in shares) at Sep. 30, 2022   84,746          
Beginning balance (in shares) at Sep. 30, 2022         27,682    
Balance at Sep. 30, 2022 477,570 $ 21,187 627,982 344,060 $ (420,116) (82,738) (12,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 48,702     48,702      
Dividend (6,145)     (6,145)      
Shares withheld on employee taxes on vested equity awards (in shares)         345    
Shares withheld on employee taxes on vested equity awards (12,734)   0   $ (12,734)    
Amortization of deferred compensation 571           571
Equity awards granted, net (in shares)   0     (467)    
Equity awards granted, net 0 $ 0 (7,082)   $ 7,082    
ESOP allocation of common stock 1,127   1,127        
Stock-based compensation 5,538   5,538        
Other comprehensive income, net of tax 12,219         12,219  
Ending balance (in shares) at Dec. 31, 2022   84,746          
Ending balance (in shares) at Dec. 31, 2022         27,560    
Balance at Dec. 31, 2022 526,848 $ 21,187 627,565 386,617 $ (425,768) (70,519) (12,234)
Beginning balance (in shares) at Sep. 30, 2022   84,746          
Beginning balance (in shares) at Sep. 30, 2022         27,682    
Balance at Sep. 30, 2022 477,570 $ 21,187 627,982 344,060 $ (420,116) (82,738) (12,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (13,553)            
Other comprehensive income, net of tax 14,832            
Ending balance (in shares) at Mar. 31, 2023   84,746          
Ending balance (in shares) at Mar. 31, 2023         27,541    
Balance at Mar. 31, 2023 468,311 $ 21,187 633,451 318,648 $ (425,405) (67,906) (11,664)
Beginning balance (in shares) at Dec. 31, 2022   84,746          
Beginning balance (in shares) at Dec. 31, 2022         27,560    
Balance at Dec. 31, 2022 526,848 $ 21,187 627,565 386,617 $ (425,768) (70,519) (12,234)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (62,255)     (62,255)      
Dividend (5,714)     (5,714)      
Shares withheld on employee taxes on vested equity awards (in shares)         21    
Shares withheld on employee taxes on vested equity awards (254)       $ (254)    
Amortization of deferred compensation 570           570
Equity awards granted, net (in shares)   0     (40)    
Equity awards granted, net 0 $ 0 (617)   $ 617    
ESOP allocation of common stock 1,207   1,207        
Stock-based compensation 5,296   5,296        
Other comprehensive income, net of tax 2,613         2,613  
Ending balance (in shares) at Mar. 31, 2023   84,746          
Ending balance (in shares) at Mar. 31, 2023         27,541    
Balance at Mar. 31, 2023 $ 468,311 $ 21,187 $ 633,451 $ 318,648 $ (425,405) $ (67,906) $ (11,664)